| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule motor activity | 1.29e-07 | 70 | 112 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.34e-07 | 118 | 112 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B KIF23 KIF21A CFTR RGS4 KIF7 RHOA RHOB RHOC GNA13 MOV10L1 KIF2A KIF5B KIF17 ATP2A3 | 2.82e-05 | 775 | 112 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | microtubule binding | 6.02e-05 | 308 | 112 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B KIF23 KIF21A CFTR RGS4 KIF7 RHOA RHOB RHOC GNA13 MOV10L1 KIF2A KIF5B KIF17 ATP2A3 | 6.96e-05 | 839 | 112 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B KIF23 KIF21A CFTR RGS4 KIF7 RHOA RHOB RHOC GNA13 MOV10L1 KIF2A KIF5B KIF17 ATP2A3 | 7.05e-05 | 840 | 112 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B KIF23 KIF21A CFTR RGS4 KIF7 RHOA RHOB RHOC GNA13 MOV10L1 KIF2A KIF5B KIF17 ATP2A3 | 7.05e-05 | 840 | 112 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | tubulin binding | KIF21B RANBP10 KIF23 KIF21A KIF7 CCDC88C KIF2A KIF5B KIF17 NIN | 1.49e-04 | 428 | 112 | 10 | GO:0015631 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B KIF23 KIF21A CFTR KIF7 MOV10L1 KIF2A KIF5B KIF17 ATP2A3 | 1.90e-04 | 441 | 112 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.28e-04 | 231 | 112 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B RANBP10 KIF23 MYO7A KIF21A FMNL2 KIF7 SMTN FMNL3 RHOA CCDC88C KIF2A KIF5B CTNNA2 KIF17 NIN | 4.14e-04 | 1099 | 112 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 4.61e-04 | 6 | 112 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 4.61e-04 | 6 | 112 | 2 | GO:0140684 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RANBP10 KALRN RGS4 CCDC88C ARHGEF33 GNA13 HERC2 DNMBP ACAP3 NCKAP1L | 5.70e-04 | 507 | 112 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RANBP10 KALRN RGS4 CCDC88C ARHGEF33 GNA13 HERC2 DNMBP ACAP3 NCKAP1L | 5.70e-04 | 507 | 112 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 6.43e-04 | 7 | 112 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | chloride channel inhibitor activity | 6.43e-04 | 7 | 112 | 2 | GO:0019869 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B KIF23 MYO7A KIF21A CFTR KIF7 MOV10L1 KIF2A KIF5B KIF17 ATP2A3 | 6.72e-04 | 614 | 112 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.80e-03 | 43 | 112 | 3 | GO:0001965 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SPARC NCKAP1 KALRN MYO7A CFAP43 THOC2 FMNL2 FMNL3 RHOA CCDC88C CSF1R CELSR2 GNA13 IGHM PKHD1 ALCAM KIF5B CTNNA2 DNMBP KDM1A NCKAP1L NIN | 2.00e-07 | 1194 | 108 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF21B RANBP10 KIF23 MCPH1 KIF21A E2F4 CFAP43 KIF7 RHOA CCDC88C GTF2B CELSR2 FBXW5 PKHD1 KIF2A KIF5B KIF17 UVRAG HYDIN NIN | 5.28e-07 | 1058 | 108 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | dendritic transport | 2.59e-06 | 19 | 108 | 4 | GO:0098935 | |
| GeneOntologyBiologicalProcess | modification of synaptic structure | 6.95e-06 | 51 | 108 | 5 | GO:0099563 | |
| GeneOntologyBiologicalProcess | regulation of modification of synaptic structure | 1.53e-05 | 29 | 108 | 4 | GO:1905244 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | RANBP10 KIF23 MCPH1 E2F4 CFAP43 RHOA CCDC88C GTF2B FBXW5 PKHD1 KIF2A UVRAG HYDIN NIN | 2.37e-05 | 720 | 108 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell migration | 2.72e-05 | 2 | 108 | 2 | GO:1902766 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF21B KIF23 KIF21A CFAP43 KIF7 CCDC88C CELSR2 KIF2A KIF5B KIF17 HYDIN | 5.57e-05 | 493 | 108 | 11 | GO:0007018 |
| GeneOntologyBiologicalProcess | modification of postsynaptic structure | 6.83e-05 | 42 | 108 | 4 | GO:0099010 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 8.98e-05 | 45 | 108 | 4 | GO:0030866 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 1.91e-04 | 302 | 108 | 8 | GO:0022604 | |
| GeneOntologyBiologicalProcess | regulation of modification of postsynaptic structure | 2.00e-04 | 22 | 108 | 3 | GO:0099159 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 2.27e-04 | 57 | 108 | 4 | GO:0030865 | |
| GeneOntologyCellularComponent | kinesin complex | 7.03e-09 | 49 | 111 | 7 | GO:0005871 | |
| GeneOntologyCellularComponent | microtubule organizing center | KIF23 MCPH1 DCDC2B KMT2E SPPL2B SKI BBS9 KIF7 SMTN CCDC88C PKHD1 KIF2A KIF5B HERC2 KIF17 UVRAG NIN | 6.89e-06 | 919 | 111 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.45e-05 | 161 | 111 | 7 | GO:0005875 | |
| Domain | Kinesin_motor_CS | 4.38e-09 | 41 | 112 | 7 | IPR019821 | |
| Domain | Kinesin-like_fam | 6.22e-09 | 43 | 112 | 7 | IPR027640 | |
| Domain | - | 7.36e-09 | 44 | 112 | 7 | 3.40.850.10 | |
| Domain | Kinesin | 7.36e-09 | 44 | 112 | 7 | PF00225 | |
| Domain | KISc | 7.36e-09 | 44 | 112 | 7 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 7.36e-09 | 44 | 112 | 7 | PS00411 | |
| Domain | Kinesin_motor_dom | 7.36e-09 | 44 | 112 | 7 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 7.36e-09 | 44 | 112 | 7 | PS50067 | |
| Domain | Nck-associated_protein-1 | 3.56e-05 | 2 | 112 | 2 | IPR019137 | |
| Domain | Nckap1 | 3.56e-05 | 2 | 112 | 2 | PF09735 | |
| Domain | P-loop_NTPase | KIF21B KIF23 MYO7A KIF21A CFTR KIF7 RHOA RHOB RHOC LRRIQ1 GNA13 MOV10L1 KIF2A KIF5B KIF17 HYDIN | 4.53e-05 | 848 | 112 | 16 | IPR027417 |
| Domain | TECPR | 1.07e-04 | 3 | 112 | 2 | SM00706 | |
| Domain | Beta-propeller_rpt_TECPR | 1.07e-04 | 3 | 112 | 2 | IPR006624 | |
| Domain | Carboxyl_trans | 2.12e-04 | 4 | 112 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 2.12e-04 | 4 | 112 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 2.12e-04 | 4 | 112 | 2 | PS50980 | |
| Domain | COA_CT_N | 2.12e-04 | 4 | 112 | 2 | IPR011762 | |
| Domain | COA_CT_C | 2.12e-04 | 4 | 112 | 2 | IPR011763 | |
| Domain | Carboxyl_trans | 2.12e-04 | 4 | 112 | 2 | IPR000022 | |
| Domain | RHO | 2.22e-04 | 20 | 112 | 3 | PS51420 | |
| Domain | Drf_GBD | 1.25e-03 | 9 | 112 | 2 | PF06371 | |
| Domain | Drf_FH3 | 1.25e-03 | 9 | 112 | 2 | PF06367 | |
| Domain | FH3_dom | 1.25e-03 | 9 | 112 | 2 | IPR010472 | |
| Domain | GTPase-bd | 1.25e-03 | 9 | 112 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 1.25e-03 | 9 | 112 | 2 | SM01139 | |
| Domain | Drf_GBD | 1.25e-03 | 9 | 112 | 2 | SM01140 | |
| Domain | WD40_repeat | 1.27e-03 | 272 | 112 | 7 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.44e-03 | 278 | 112 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.47e-03 | 279 | 112 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.47e-03 | 279 | 112 | 7 | PS50294 | |
| Domain | GBD/FH3_dom | 1.89e-03 | 11 | 112 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 1.89e-03 | 11 | 112 | 2 | PS51232 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.26e-03 | 12 | 112 | 2 | IPR011041 | |
| Domain | - | 2.26e-03 | 12 | 112 | 2 | 1.50.10.20 | |
| Domain | EF_HAND_2 | 2.70e-03 | 231 | 112 | 6 | PS50222 | |
| Domain | EF_hand_dom | 2.76e-03 | 232 | 112 | 6 | IPR002048 | |
| Domain | FH2 | 3.56e-03 | 15 | 112 | 2 | PS51444 | |
| Domain | FH2_Formin | 3.56e-03 | 15 | 112 | 2 | IPR015425 | |
| Domain | FH2 | 3.56e-03 | 15 | 112 | 2 | PF02181 | |
| Domain | FH2 | 3.56e-03 | 15 | 112 | 2 | SM00498 | |
| Domain | EF_Hand_1_Ca_BS | 4.08e-03 | 175 | 112 | 5 | IPR018247 | |
| Domain | - | 4.90e-03 | 261 | 112 | 6 | 1.10.238.10 | |
| Domain | Ig/MHC_CS | 5.10e-03 | 58 | 112 | 3 | IPR003006 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.12e-03 | 18 | 112 | 2 | IPR008930 | |
| Domain | WD40 | 5.56e-03 | 268 | 112 | 6 | SM00320 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | NCKAP1 CFTR FMNL2 FMNL3 CENPP RHOA RHOB RHOC KIF2A KIF5B NCKAP1L | 6.97e-07 | 257 | 90 | 11 | MM14755 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | NCKAP1 CFTR FMNL2 FMNL3 CENPP RHOA RHOB RHOC KIF2A KIF5B KDM1A NCKAP1L | 9.44e-07 | 323 | 90 | 12 | M27080 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.49e-06 | 5 | 90 | 3 | MM15221 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 8.65e-06 | 7 | 90 | 3 | MM15217 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 9.43e-06 | 77 | 90 | 6 | MM15044 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCKAP1 KALRN CFTR FMNL2 FMNL3 CENPP RHOA RHOB RHOC GFOD1 GNA13 KIF2A KIF5B DNMBP KDM1A NCKAP1L | 1.13e-05 | 720 | 90 | 16 | M41838 |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.18e-05 | 80 | 90 | 6 | M800 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCKAP1 KALRN CFTR FMNL2 FMNL3 CENPP RHOA RHOB RHOC GFOD1 GNA13 KIF2A KIF5B DNMBP NCKAP1L | 1.39e-05 | 649 | 90 | 15 | MM15690 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS | 2.06e-05 | 9 | 90 | 3 | M27551 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | NCKAP1 KALRN CFTR FMNL2 FMNL3 RHOA RHOB RHOC GFOD1 GNA13 DNMBP NCKAP1L | 2.17e-05 | 439 | 90 | 12 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | NCKAP1 KALRN CFTR FMNL2 FMNL3 RHOA RHOB RHOC GFOD1 GNA13 DNMBP NCKAP1L | 2.77e-05 | 450 | 90 | 12 | M27078 |
| Pathway | REACTOME_KINESINS | 3.06e-05 | 57 | 90 | 5 | MM15714 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.08e-05 | 140 | 90 | 7 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.23e-05 | 141 | 90 | 7 | MM15266 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 4.00e-05 | 11 | 90 | 3 | MM15046 | |
| Pathway | REACTOME_KINESINS | 4.26e-05 | 61 | 90 | 5 | M977 | |
| Pathway | REACTOME_HEMOSTASIS | KIF21B KIF23 SPARC VWF KIF21A ECM1 RHOA RHOB GNA13 KIF2A KIF5B ATP2A3 KDM1A | 6.46e-05 | 571 | 90 | 13 | MM14472 |
| Pathway | REACTOME_HEMOSTASIS | KIF21B KIF23 SPARC VWF KIF21A ECM1 RHOA RHOB GNA13 IGHM KIF2A KIF5B ATP2A3 KDM1A | 9.57e-05 | 679 | 90 | 14 | M8395 |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 9.67e-05 | 116 | 90 | 6 | MM15715 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.08e-04 | 15 | 90 | 3 | MM15037 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.26e-04 | 19 | 90 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 2.26e-04 | 19 | 90 | 3 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.65e-04 | 20 | 90 | 3 | M18415 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 2.92e-04 | 142 | 90 | 6 | MM15431 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.04e-04 | 98 | 90 | 5 | MM15352 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 4.06e-04 | 23 | 90 | 3 | MM15216 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.43e-04 | 100 | 90 | 5 | M27650 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 4.51e-04 | 154 | 90 | 6 | M27697 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 4.62e-04 | 24 | 90 | 3 | M2243 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 7.60e-04 | 170 | 90 | 6 | M941 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.03e-03 | 70 | 90 | 4 | MM15597 | |
| Pathway | REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM | 1.10e-03 | 8 | 90 | 2 | M27248 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.27e-03 | 74 | 90 | 4 | M41807 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.31e-03 | 189 | 90 | 6 | MM15356 | |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 2.20e-09 | 37 | 113 | 6 | 11416179 | |
| Pubmed | KIF21B RANBP10 KIF23 NCKAP1 KALRN KIF21A TMEM132B KIF7 RHOC CCDC88C IGF2R CELSR2 KIF2A KIF5B CTNNA2 HERC2 KDM1A | 1.51e-08 | 963 | 113 | 17 | 28671696 | |
| Pubmed | RhoA, RhoB and RhoC have different roles in cancer cell migration. | 3.34e-08 | 3 | 113 | 3 | 23488932 | |
| Pubmed | A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. | 3.34e-08 | 3 | 113 | 3 | 12939257 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 29500478 | ||
| Pubmed | RhoA, RhoB and RhoC differentially regulate endothelial barrier function. | 3.34e-08 | 3 | 113 | 3 | 28949796 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 19477269 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 22673745 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 26741994 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 15642170 | ||
| Pubmed | Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. | 3.34e-08 | 3 | 113 | 3 | 27147504 | |
| Pubmed | Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. | 1.33e-07 | 4 | 113 | 3 | 10559899 | |
| Pubmed | XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. | 1.33e-07 | 4 | 113 | 3 | 12221096 | |
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 8662891 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 22992742 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 8617235 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 15093731 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 8543060 | ||
| Pubmed | Small GTP-binding proteins and the regulation of the actin cytoskeleton. | 6.63e-07 | 6 | 113 | 3 | 7888179 | |
| Pubmed | 6.63e-07 | 6 | 113 | 3 | 9438836 | ||
| Pubmed | Dissecting the role of Rho-mediated signaling in contractile ring formation. | 6.63e-07 | 6 | 113 | 3 | 16236794 | |
| Pubmed | 6.63e-07 | 6 | 113 | 3 | 19286565 | ||
| Pubmed | RHO binding to FAM65A regulates Golgi reorientation during cell migration. | 1.16e-06 | 7 | 113 | 3 | 27807006 | |
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 1.27e-06 | 25 | 113 | 4 | 9275178 | |
| Pubmed | KIF23 MED16 THOC2 KIF7 RHOA GTF2B IPO9 C3 KIF5B KDM1A RPAP2 NIN | 1.34e-06 | 645 | 113 | 12 | 25281560 | |
| Pubmed | 2.04e-06 | 28 | 113 | 4 | 18839057 | ||
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 15151987 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RANBP10 ACACA KALRN MYO7A CFAP43 SPPL2B REXO1 CPTP CCDC88C IGF2R CELSR2 HERC2 DNMBP ATP2A3 UVRAG | 3.05e-06 | 1105 | 113 | 15 | 35748872 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | KIF21B SYT12 NCKAP1 KIF21A BLZF1 RGS4 SLC25A12 GNA13 KIF2A KIF5B ATP2A3 | 6.04e-06 | 621 | 113 | 11 | 22794259 |
| Pubmed | Kctd13 deletion reduces synaptic transmission via increased RhoA. | 9.33e-06 | 13 | 113 | 3 | 29088697 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 33162807 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21454503 | ||
| Pubmed | Activation of a bacterial virulence protein by the GTPase RhoA. | 1.05e-05 | 2 | 113 | 2 | 19887681 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10225949 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 3283705 | ||
| Pubmed | Functional analysis of the promoters of the small GTPases RhoA and RhoB in embryonic stem cells. | 1.05e-05 | 2 | 113 | 2 | 28739254 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12808121 | ||
| Pubmed | Kinesin-1 plays multiple roles during the vaccinia virus life cycle. | 1.05e-05 | 2 | 113 | 2 | 17394562 | |
| Pubmed | Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease. | 1.05e-05 | 2 | 113 | 2 | 34329764 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28960175 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31751425 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20503409 | ||
| Pubmed | Guanine nucleotide exchange regulates membrane translocation of Rac/Rho GTP-binding proteins. | 1.05e-05 | 2 | 113 | 2 | 7989340 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26616858 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 33825439 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20828398 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15668138 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17896152 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 7643388 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 7835413 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 3888408 | ||
| Pubmed | Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB. | 1.05e-05 | 2 | 113 | 2 | 29059167 | |
| Pubmed | Chromosome localization of human ARH genes, a ras-related gene family. | 1.05e-05 | 2 | 113 | 2 | 2407642 | |
| Pubmed | The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins. | 1.05e-05 | 2 | 113 | 2 | 27424208 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28327544 | ||
| Pubmed | GTPases Rho distribution in intraepithelial and invasive neoplasias of the uterine cervix. | 1.05e-05 | 2 | 113 | 2 | 24984542 | |
| Pubmed | ABCs of RhoGTPases indicating potential role as oncotargets. | 1.05e-05 | 2 | 113 | 2 | 28508825 | |
| Pubmed | Immunolocalization of RhoA and RhoB GTPases in pleomorphic adenoma of the parotid. | 1.05e-05 | 2 | 113 | 2 | 25454559 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19499974 | ||
| Pubmed | Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. | 1.05e-05 | 2 | 113 | 2 | 20101212 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22790947 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19414754 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30892081 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22045984 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21208644 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19642867 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACA NCKAP1 ACOT9 OSGEP KIF7 CCDC88C IGF2R KIF5B HERC2 DNMBP PCCB NIN | 2.25e-05 | 853 | 113 | 12 | 28718761 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ACACA MCPH1 MYO7A KIF21A HLA-G FMNL2 TMEM132B RHOA KDM4D ARHGEF33 PKHD1 | 2.91e-05 | 736 | 113 | 11 | 29676528 |
| Pubmed | 3.01e-05 | 371 | 113 | 8 | 15747579 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 1400319 | ||
| Pubmed | Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. | 3.13e-05 | 3 | 113 | 2 | 30429364 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18922893 | ||
| Pubmed | Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice. | 3.13e-05 | 3 | 113 | 2 | 27688803 | |
| Pubmed | RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha. | 3.13e-05 | 3 | 113 | 2 | 18524772 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 17018591 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24096540 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 38395901 | ||
| Pubmed | Structural and mechanistic insights into the interaction between Rho and mammalian Dia. | 3.13e-05 | 3 | 113 | 2 | 15864301 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24022220 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18694745 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19377048 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 20889566 | ||
| Pubmed | A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC. | 3.13e-05 | 3 | 113 | 2 | 21087931 | |
| Pubmed | RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication. | 3.13e-05 | 3 | 113 | 2 | 20697357 | |
| Pubmed | Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases. | 3.13e-05 | 3 | 113 | 2 | 24447566 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 11788600 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 11741970 | ||
| Pubmed | SWAP-70 regulates RhoA/RhoB-dependent MHCII surface localization in dendritic cells. | 3.13e-05 | 3 | 113 | 2 | 18802007 | |
| Pubmed | RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis. | 3.13e-05 | 3 | 113 | 2 | 21757538 | |
| Pubmed | Selective expression of the small GTPase RhoB in the early developing mouse lens. | 3.13e-05 | 3 | 113 | 2 | 11747086 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 30728330 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 23023331 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 28536953 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 31148579 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 12526796 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24782506 | ||
| Pubmed | Complement in breast milk modifies offspring gut microbiota to promote infant health. | 3.13e-05 | 3 | 113 | 2 | 38242132 | |
| Pubmed | Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. | 3.13e-05 | 3 | 113 | 2 | 12684686 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19421144 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24175013 | ||
| Interaction | SBF1 interactions | 2.33e-07 | 157 | 112 | 9 | int:SBF1 | |
| Interaction | CTNNA1 interactions | MYO7A CFTR E2F4 FMNL2 RHOA RHOB RHOC CCDC88C IPO9 CTNNA2 HERC2 PLCH1 | 5.31e-07 | 347 | 112 | 12 | int:CTNNA1 |
| Interaction | DAAM1 interactions | 2.98e-06 | 72 | 112 | 6 | int:DAAM1 | |
| Interaction | DIAPH3 interactions | 6.30e-06 | 125 | 112 | 7 | int:DIAPH3 | |
| Interaction | DIAPH1 interactions | 6.34e-06 | 176 | 112 | 8 | int:DIAPH1 | |
| Interaction | SLK interactions | 8.44e-06 | 183 | 112 | 8 | int:SLK | |
| Interaction | BICD1 interactions | 1.09e-05 | 250 | 112 | 9 | int:BICD1 | |
| Interaction | FZD6 interactions | 1.35e-05 | 55 | 112 | 5 | int:FZD6 | |
| Interaction | IQGAP3 interactions | 1.39e-05 | 141 | 112 | 7 | int:IQGAP3 | |
| Interaction | PHLDB2 interactions | 1.52e-05 | 143 | 112 | 7 | int:PHLDB2 | |
| Interaction | SLC38A5 interactions | 2.53e-05 | 31 | 112 | 4 | int:SLC38A5 | |
| Interaction | PKP4 interactions | 3.02e-05 | 159 | 112 | 7 | int:PKP4 | |
| Interaction | TENM2 interactions | 3.54e-05 | 12 | 112 | 3 | int:TENM2 | |
| Interaction | IFT122 interactions | 3.56e-05 | 67 | 112 | 5 | int:IFT122 | |
| Interaction | GPRC5A interactions | 3.82e-05 | 68 | 112 | 5 | int:GPRC5A | |
| Interaction | MED4 interactions | KIF21B MED16 POLR2G THOC2 KIF7 GTF2B C3 KIF5B HERC2 RPAP2 NIN | 4.22e-05 | 450 | 112 | 11 | int:MED4 |
| Interaction | TANGO6 interactions | 4.71e-05 | 71 | 112 | 5 | int:TANGO6 | |
| Interaction | GNA11 interactions | 4.88e-05 | 117 | 112 | 6 | int:GNA11 | |
| Interaction | FAT4 interactions | 5.04e-05 | 72 | 112 | 5 | int:FAT4 | |
| Interaction | MUC13 interactions | 5.18e-05 | 37 | 112 | 4 | int:MUC13 | |
| Interaction | SLC11A2 interactions | 5.77e-05 | 38 | 112 | 4 | int:SLC11A2 | |
| Interaction | POLR2G interactions | 6.41e-05 | 179 | 112 | 7 | int:POLR2G | |
| Interaction | HTT interactions | KIF21B KIF23 SYT12 NCKAP1 KIF21A BLZF1 RGS4 RHOA RHOC IPO9 SLC25A12 GNA13 KIF2A KIF5B ATP2A3 KDM1A | 7.02e-05 | 949 | 112 | 16 | int:HTT |
| Interaction | NECTIN3 interactions | 7.41e-05 | 78 | 112 | 5 | int:NECTIN3 | |
| Interaction | CCN1 interactions | 8.60e-05 | 42 | 112 | 4 | int:CCN1 | |
| Interaction | DBNL interactions | 9.33e-05 | 190 | 112 | 7 | int:DBNL | |
| Interaction | KRIT1 interactions | 1.03e-04 | 44 | 112 | 4 | int:KRIT1 | |
| Interaction | PCCA interactions | 1.04e-04 | 134 | 112 | 6 | int:PCCA | |
| Interaction | MED30 interactions | 1.05e-04 | 84 | 112 | 5 | int:MED30 | |
| Interaction | RHOA interactions | NCKAP1 ACOT9 CFTR OSGEP CPT1A CLOCK FMNL2 FMNL3 RHOA RHOB RHOC CCDC88C IPO9 IGF2R SLC25A12 GNA13 CTNNA2 PLCH1 | 1.06e-04 | 1199 | 112 | 18 | int:RHOA |
| Interaction | SAMD3 interactions | 1.07e-04 | 17 | 112 | 3 | int:SAMD3 | |
| Interaction | GNAS interactions | 1.15e-04 | 264 | 112 | 8 | int:GNAS | |
| Interaction | PARD3B interactions | 1.23e-04 | 46 | 112 | 4 | int:PARD3B | |
| Interaction | ITGA1 interactions | 1.23e-04 | 46 | 112 | 4 | int:ITGA1 | |
| Interaction | SLCO4A1 interactions | 1.23e-04 | 46 | 112 | 4 | int:SLCO4A1 | |
| Interaction | SLC16A1 interactions | 1.28e-04 | 200 | 112 | 7 | int:SLC16A1 | |
| Interaction | ACSL4 interactions | 1.32e-04 | 140 | 112 | 6 | int:ACSL4 | |
| Interaction | NHS interactions | 1.46e-04 | 48 | 112 | 4 | int:NHS | |
| Interaction | MYO1G interactions | 1.52e-04 | 19 | 112 | 3 | int:MYO1G | |
| Interaction | BLTP1 interactions | 1.58e-04 | 49 | 112 | 4 | int:BLTP1 | |
| Interaction | TOP3B interactions | RANBP10 KIF23 ACACA KALRN MYO7A CFAP43 SPPL2B THOC2 REXO1 RHOA CPTP RHOC CCDC88C IGF2R CELSR2 HERC2 KLHL14 DNMBP ATP2A3 UVRAG | 1.60e-04 | 1470 | 112 | 20 | int:TOP3B |
| Interaction | B2M interactions | 1.62e-04 | 92 | 112 | 5 | int:B2M | |
| Interaction | CEP89 interactions | 1.72e-04 | 147 | 112 | 6 | int:CEP89 | |
| Interaction | KIF27 interactions | 1.78e-04 | 20 | 112 | 3 | int:KIF27 | |
| Interaction | SLC6A9 interactions | 1.78e-04 | 20 | 112 | 3 | int:SLC6A9 | |
| Interaction | GNA13 interactions | 1.79e-04 | 148 | 112 | 6 | int:GNA13 | |
| Interaction | TMEM277P interactions | 1.82e-04 | 4 | 112 | 2 | int:TMEM277P | |
| Interaction | PPFIA1 interactions | 1.95e-04 | 214 | 112 | 7 | int:PPFIA1 | |
| Interaction | PAK2 interactions | 2.06e-04 | 216 | 112 | 7 | int:PAK2 | |
| Interaction | CRIM1 interactions | 2.07e-04 | 21 | 112 | 3 | int:CRIM1 | |
| Interaction | TJP2 interactions | 2.08e-04 | 288 | 112 | 8 | int:TJP2 | |
| Interaction | CAVIN1 interactions | 2.28e-04 | 292 | 112 | 8 | int:CAVIN1 | |
| Interaction | COPB1 interactions | 2.39e-04 | 294 | 112 | 8 | int:COPB1 | |
| Interaction | RAP2C interactions | 2.48e-04 | 55 | 112 | 4 | int:RAP2C | |
| Interaction | TNIK interactions | 2.78e-04 | 381 | 112 | 9 | int:TNIK | |
| Interaction | GIMAP4 interactions | 3.03e-04 | 5 | 112 | 2 | int:GIMAP4 | |
| Interaction | RICTOR interactions | B4GALT2 KIF23 CIB2 ACOT9 CPT1A RHOA RHOB RHOC IPO9 IGF2R FBXW5 KIF5B NCKAP1L | 3.04e-04 | 759 | 112 | 13 | int:RICTOR |
| Interaction | MED19 interactions | 3.14e-04 | 106 | 112 | 5 | int:MED19 | |
| Interaction | RRAS2 interactions | 3.58e-04 | 109 | 112 | 5 | int:RRAS2 | |
| Interaction | WDR6 interactions | 3.71e-04 | 314 | 112 | 8 | int:WDR6 | |
| Interaction | BMPR2 interactions | 3.73e-04 | 110 | 112 | 5 | int:BMPR2 | |
| Interaction | YWHAH interactions | KIF21B KIF23 NCKAP1 CFTR ISOC1 SIK1 KIF7 CCDC88C IPO9 USP4 KIF2A KIF5B PLCH1 DNMBP UVRAG NIN | 3.85e-04 | 1102 | 112 | 16 | int:YWHAH |
| Interaction | SLITRK4 interactions | 3.96e-04 | 26 | 112 | 3 | int:SLITRK4 | |
| Interaction | FXR1 interactions | KIF23 VWF KIF21A E2F4 THOC2 ECM1 KIF7 RHOA KIF2A HERC2 PCCB KIF17 | 3.96e-04 | 679 | 112 | 12 | int:FXR1 |
| Interaction | HACD3 interactions | 4.10e-04 | 242 | 112 | 7 | int:HACD3 | |
| Interaction | MYO9B interactions | 4.22e-04 | 113 | 112 | 5 | int:MYO9B | |
| Interaction | PREX2 interactions | 4.43e-04 | 27 | 112 | 3 | int:PREX2 | |
| Interaction | ZNFX1 interactions | 4.44e-04 | 64 | 112 | 4 | int:ZNFX1 | |
| Interaction | CCDC77 interactions | 4.44e-04 | 64 | 112 | 4 | int:CCDC77 | |
| Interaction | TMEM185B interactions | 4.53e-04 | 6 | 112 | 2 | int:TMEM185B | |
| Interaction | MACF1 interactions | 4.64e-04 | 247 | 112 | 7 | int:MACF1 | |
| Interaction | PPFIBP1 interactions | 4.67e-04 | 177 | 112 | 6 | int:PPFIBP1 | |
| Interaction | YWHAB interactions | KIF21B KIF23 SPARC NCKAP1 CFTR SIK1 CCDC88C IPO9 USP4 KIF2A KIF5B PLCH1 DNMBP MAP2K6 UVRAG | 4.90e-04 | 1014 | 112 | 15 | int:YWHAB |
| Interaction | B3GALT6 interactions | 4.95e-04 | 28 | 112 | 3 | int:B3GALT6 | |
| Interaction | ARHGEF12 interactions | 4.95e-04 | 117 | 112 | 5 | int:ARHGEF12 | |
| Interaction | YWHAG interactions | KIF21B KIF23 SPARC NCKAP1 CFTR SIK1 KIF7 RHOA RHOB RHOC CCDC88C IPO9 KIF2A KIF5B PLCH1 DNMBP UVRAG | 5.20e-04 | 1248 | 112 | 17 | int:YWHAG |
| Interaction | MED20 interactions | 5.26e-04 | 181 | 112 | 6 | int:MED20 | |
| Interaction | LGALS1 interactions | 5.37e-04 | 332 | 112 | 8 | int:LGALS1 | |
| Interaction | ROCK2 interactions | 5.42e-04 | 182 | 112 | 6 | int:ROCK2 | |
| Interaction | DOCK7 interactions | 5.48e-04 | 254 | 112 | 7 | int:DOCK7 | |
| Interaction | PFN1 interactions | 5.48e-04 | 509 | 112 | 10 | int:PFN1 | |
| Interaction | SYT12 interactions | 5.50e-04 | 29 | 112 | 3 | int:SYT12 | |
| Interaction | SOWAHC interactions | 5.50e-04 | 29 | 112 | 3 | int:SOWAHC | |
| Interaction | FLRT2 interactions | 5.50e-04 | 29 | 112 | 3 | int:FLRT2 | |
| Interaction | OLR1 interactions | 5.50e-04 | 29 | 112 | 3 | int:OLR1 | |
| Interaction | PRPF18 interactions | 5.56e-04 | 120 | 112 | 5 | int:PRPF18 | |
| Interaction | MFAP3 interactions | 5.60e-04 | 68 | 112 | 4 | int:MFAP3 | |
| Interaction | DIAPH2 interactions | 5.60e-04 | 68 | 112 | 4 | int:DIAPH2 | |
| Interaction | RALGAPB interactions | 5.60e-04 | 68 | 112 | 4 | int:RALGAPB | |
| Interaction | SURF4 interactions | 5.74e-04 | 184 | 112 | 6 | int:SURF4 | |
| Interaction | SPTBN1 interactions | 5.74e-04 | 421 | 112 | 9 | int:SPTBN1 | |
| Interaction | FMNL2 interactions | 5.90e-04 | 185 | 112 | 6 | int:FMNL2 | |
| Interaction | EHD2 interactions | 5.92e-04 | 69 | 112 | 4 | int:EHD2 | |
| Interaction | RBBP8 interactions | 5.99e-04 | 122 | 112 | 5 | int:RBBP8 | |
| Interaction | TGFBR1 interactions | 6.01e-04 | 258 | 112 | 7 | int:TGFBR1 | |
| Interaction | ARHGAP8 interactions | 6.08e-04 | 30 | 112 | 3 | int:ARHGAP8 | |
| Interaction | CMIP interactions | 6.08e-04 | 30 | 112 | 3 | int:CMIP | |
| Interaction | GNB4 interactions | 6.22e-04 | 123 | 112 | 5 | int:GNB4 | |
| Interaction | EPB41L1 interactions | 6.24e-04 | 187 | 112 | 6 | int:EPB41L1 | |
| Interaction | KIDINS220 interactions | 6.24e-04 | 187 | 112 | 6 | int:KIDINS220 | |
| Cytoband | 17q24.3 | 9.63e-06 | 17 | 113 | 3 | 17q24.3 | |
| Cytoband | 11q13.5 | 1.87e-05 | 21 | 113 | 3 | 11q13.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 9.44e-05 | 183 | 113 | 5 | chr16q22 | |
| Cytoband | 1p36.12 | 1.24e-04 | 39 | 113 | 3 | 1p36.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 1.86e-03 | 98 | 113 | 3 | chr17q24 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.55e-10 | 46 | 70 | 7 | 622 | |
| GeneFamily | Rho family GTPases | 6.04e-05 | 20 | 70 | 3 | 390 | |
| GeneFamily | EF-hand domain containing | 1.59e-03 | 219 | 70 | 5 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.14e-03 | 66 | 70 | 3 | 722 | |
| GeneFamily | WD repeat domain containing | 3.46e-03 | 262 | 70 | 5 | 362 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.86e-03 | 24 | 70 | 2 | 485 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 3.64e-06 | 54 | 113 | 5 | M4737 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 6.77e-06 | 228 | 113 | 8 | MM3676 | |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP | POLR2G ISOC1 ECM1 FMNL2 RHOC GFOD1 C3 KIF2A ALCAM KIF5B MAP2K6 ATP2A3 | 8.70e-06 | 585 | 113 | 12 | M6659 |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN | 2.64e-05 | 200 | 113 | 7 | M9641 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 160 | 113 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 160 | 113 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-07 | 175 | 113 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.53e-07 | 194 | 113 | 7 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 7.49e-07 | 198 | 113 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.01e-07 | 200 | 113 | 7 | fe493b0454a20498e9ada482bf55de64519f6c35 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.82e-06 | 170 | 113 | 6 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.68e-06 | 180 | 113 | 6 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-06 | 185 | 113 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-06 | 185 | 113 | 6 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-06 | 185 | 113 | 6 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-06 | 185 | 113 | 6 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.57e-06 | 188 | 113 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.57e-06 | 188 | 113 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 9.10e-06 | 190 | 113 | 6 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.10e-06 | 190 | 113 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.66e-06 | 192 | 113 | 6 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.02e-05 | 194 | 113 | 6 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 1.02e-05 | 194 | 113 | 6 | d70b9039fd2fef3e4be086513b94fb7e9bc1f670 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 1.02e-05 | 194 | 113 | 6 | 5151546812678ae85cb22224084d27b29e3c4724 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 195 | 113 | 6 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 195 | 113 | 6 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-05 | 195 | 113 | 6 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-05 | 195 | 113 | 6 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 1.09e-05 | 196 | 113 | 6 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 196 | 113 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 197 | 113 | 6 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | COVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 1.12e-05 | 197 | 113 | 6 | c5837b9a5a39a0f607a4e217ade9fc87d82a5406 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 197 | 113 | 6 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | COVID-19_Severe-PLT_2|World / Disease Group and Platelet Clusters | 1.12e-05 | 197 | 113 | 6 | b6267c624c2e0070c34bba54bf5362466a2dbf34 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-05 | 198 | 113 | 6 | 9b8679b3dd8f4220d71f607b7080cb88d6e71129 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-05 | 198 | 113 | 6 | 8b6b602ebe59b6dca6a22f17385d3160ff3ac67e | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 1.15e-05 | 198 | 113 | 6 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 198 | 113 | 6 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 198 | 113 | 6 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-05 | 198 | 113 | 6 | b9030390316baf456135f85f831394e1e11ecf3e | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-05 | 198 | 113 | 6 | d36a3cda7e5f385d2391e9b0dfb027d3c4549320 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-05 | 198 | 113 | 6 | 5436c3ed16e10e00c686f1ab0b0a68728a1a9985 | |
| ToppCell | severe_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.15e-05 | 198 | 113 | 6 | 790ee20abc9666b8095675b0d445c0914ee70ea3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 198 | 113 | 6 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-05 | 198 | 113 | 6 | 4f67067d8142ca11b2d80195dac8d62a8d24d52c | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class | 1.22e-05 | 200 | 113 | 6 | 58fbb7fc7159cbc417e6b457d60b7beba9b90da6 | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-05 | 200 | 113 | 6 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | severe-Non-classical_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-05 | 200 | 113 | 6 | 6cc7190a4ffc6c06335072f3b5b5f98eae36e2ce | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.19e-05 | 132 | 113 | 5 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.45e-05 | 153 | 113 | 5 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.88e-05 | 156 | 113 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-05 | 157 | 113 | 5 | 432b8719a8afd289cf48068e12c26a349d753fcc | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 5.50e-05 | 160 | 113 | 5 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.01e-05 | 163 | 113 | 5 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.37e-05 | 165 | 113 | 5 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.37e-05 | 165 | 113 | 5 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.74e-05 | 167 | 113 | 5 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-05 | 169 | 113 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | ASK452-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.26e-05 | 32 | 113 | 3 | fd0777da59e8ac3e0f766071977cb169d058e5ae | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 170 | 113 | 5 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 170 | 113 | 5 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 171 | 113 | 5 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 171 | 113 | 5 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.18e-05 | 174 | 113 | 5 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 8.52e-05 | 91 | 113 | 4 | 25197fde8b9bdaf1e28add695d13aff3ff52d86e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related-Oligodendrocyte/OPC|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 8.52e-05 | 91 | 113 | 4 | ed4a48e5e5f5d8aadbc7b1b8d84a5f6363a08b85 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 177 | 113 | 5 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 177 | 113 | 5 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.87e-05 | 177 | 113 | 5 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.87e-05 | 177 | 113 | 5 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 113 | 5 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 113 | 5 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 113 | 5 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 113 | 5 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.35e-05 | 179 | 113 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.35e-05 | 179 | 113 | 5 | 7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.60e-05 | 180 | 113 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.60e-05 | 180 | 113 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.60e-05 | 180 | 113 | 5 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.60e-05 | 180 | 113 | 5 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.85e-05 | 181 | 113 | 5 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.85e-05 | 181 | 113 | 5 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.85e-05 | 181 | 113 | 5 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-05 | 181 | 113 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 182 | 113 | 5 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 183 | 113 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 183 | 113 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 113 | 5 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 183 | 113 | 5 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 183 | 113 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 113 | 5 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.04e-04 | 183 | 113 | 5 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 183 | 113 | 5 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 184 | 113 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A | 6.42e-06 | 197 | 113 | 8 | 4069_UP | |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 5731_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; HL60; HT_HG-U133A | 6.91e-06 | 199 | 113 | 8 | 2987_DN | |
| Disease | ulcerative colitis (implicated_via_orthology) | 1.84e-06 | 7 | 112 | 3 | DOID:8577 (implicated_via_orthology) | |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 2.94e-06 | 8 | 112 | 3 | DOID:0080377 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | TMCO5A MCPH1 KALRN ISOC1 ST7L FMNL2 BBS9 GTF2B PKHD1 ALCAM HERC2 | 3.95e-06 | 509 | 112 | 11 | EFO_0004695 |
| Disease | hypertension (biomarker_via_orthology) | 2.66e-05 | 227 | 112 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Ciliopathies | 6.42e-05 | 110 | 112 | 5 | C4277690 | |
| Disease | microglial activation measurement | 7.62e-05 | 59 | 112 | 4 | EFO_0010940 | |
| Disease | breast cancer (is_marker_for) | 7.73e-05 | 185 | 112 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Choledochal Cyst, Type I | 1.42e-04 | 5 | 112 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 1.42e-04 | 5 | 112 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 1.42e-04 | 5 | 112 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 1.42e-04 | 5 | 112 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 1.42e-04 | 5 | 112 | 2 | C1257799 | |
| Disease | Choledochal Cyst | 1.42e-04 | 5 | 112 | 2 | C0008340 | |
| Disease | central corneal thickness | 1.83e-04 | 309 | 112 | 7 | EFO_0005213 | |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 2.12e-04 | 6 | 112 | 2 | EFO_0803247 | |
| Disease | Usher Syndrome, Type I | 2.12e-04 | 6 | 112 | 2 | C1568247 | |
| Disease | neuroimaging measurement | KIF21B TMCO5A MCPH1 ST7L BBS9 CHRNB3 CCDC88C AMER2 LRRIQ1 GNA13 PKHD1 ALCAM PLCH1 | 2.12e-04 | 1069 | 112 | 13 | EFO_0004346 |
| Disease | Cerebral ventriculomegaly | 2.96e-04 | 7 | 112 | 2 | C1531647 | |
| Disease | regulator of G-protein signaling 8 measurement | 2.96e-04 | 7 | 112 | 2 | EFO_0801997 | |
| Disease | Hydrocephalus Ex-Vacuo | 2.96e-04 | 7 | 112 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 2.96e-04 | 7 | 112 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 2.96e-04 | 7 | 112 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 2.96e-04 | 7 | 112 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 2.96e-04 | 7 | 112 | 2 | C0549423 | |
| Disease | corneal resistance factor | 3.33e-04 | 451 | 112 | 8 | EFO_0010067 | |
| Disease | myocardial infarction | 3.88e-04 | 350 | 112 | 7 | EFO_0000612 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 3.94e-04 | 8 | 112 | 2 | EFO_0801373 | |
| Disease | Congenital Hydrocephalus | 3.94e-04 | 8 | 112 | 2 | C0020256 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1D measurement | 3.94e-04 | 8 | 112 | 2 | EFO_0008063 | |
| Disease | Aqueductal Stenosis | 3.94e-04 | 8 | 112 | 2 | C2936786 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 5.05e-04 | 9 | 112 | 2 | EFO_0801463 | |
| Disease | Hydrocephalus | 5.05e-04 | 9 | 112 | 2 | C0020255 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 5.05e-04 | 9 | 112 | 2 | C0085548 | |
| Disease | membranous glomerulonephritis (implicated_via_orthology) | 5.05e-04 | 9 | 112 | 2 | DOID:10976 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 5.68e-04 | 268 | 112 | 6 | C0001973 | |
| Disease | triglycerides in large LDL measurement | 5.88e-04 | 43 | 112 | 3 | EFO_0022319 | |
| Disease | adseverin measurement | 6.30e-04 | 10 | 112 | 2 | EFO_0801358 | |
| Disease | PR domain zinc finger protein 1 measurement | 7.68e-04 | 11 | 112 | 2 | EFO_0801904 | |
| Disease | Leukoencephalopathy | 7.68e-04 | 11 | 112 | 2 | C0270612 | |
| Disease | cocaine use | 7.68e-04 | 11 | 112 | 2 | C3496069 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 7.68e-04 | 11 | 112 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | response to virus | 7.68e-04 | 11 | 112 | 2 | GO_0009615 | |
| Disease | lipoprotein A measurement | 8.91e-04 | 112 | 112 | 4 | EFO_0006925 | |
| Disease | oncostatin-M measurement | 9.19e-04 | 12 | 112 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 9.19e-04 | 12 | 112 | 2 | EFO_0020833 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.08e-03 | 13 | 112 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 1.21e-03 | 550 | 112 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 1.26e-03 | 14 | 112 | 2 | C1858991 | |
| Disease | triglycerides in LDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022320 | |
| Disease | Disorder of eye | 1.31e-03 | 212 | 112 | 5 | C0015397 | |
| Disease | triglycerides in IDL measurement | 1.41e-03 | 58 | 112 | 3 | EFO_0022149 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.42e-03 | 127 | 112 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | docosahexaenoic acid measurement | 1.42e-03 | 127 | 112 | 4 | EFO_0007761 | |
| Disease | phospholipids in VLDL measurement | 1.48e-03 | 59 | 112 | 3 | EFO_0022301 | |
| Disease | total lipids in VLDL measurement | 1.56e-03 | 60 | 112 | 3 | EFO_0022314 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.61e-03 | 222 | 112 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | free cholesterol in VLDL measurement | 1.63e-03 | 61 | 112 | 3 | EFO_0022276 | |
| Disease | T-Cell Lymphoma | 1.65e-03 | 16 | 112 | 2 | C0079772 | |
| Disease | Global developmental delay | 1.68e-03 | 133 | 112 | 4 | C0557874 | |
| Disease | triglycerides in medium LDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022322 | |
| Disease | Ulcerative Colitis | 1.79e-03 | 63 | 112 | 3 | C0009324 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.87e-03 | 17 | 112 | 2 | C2936862 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.87e-03 | 137 | 112 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | cholesterol in large VLDL measurement | 1.96e-03 | 65 | 112 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.96e-03 | 65 | 112 | 3 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 2.14e-03 | 67 | 112 | 3 | EFO_0022148 | |
| Disease | stroke | 2.25e-03 | 144 | 112 | 4 | EFO_0000712 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.30e-03 | 145 | 112 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Congenital hernia of foramen of Morgagni | 2.34e-03 | 19 | 112 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 2.34e-03 | 19 | 112 | 2 | C0265700 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.34e-03 | 19 | 112 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.39e-03 | 243 | 112 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | visual cortical surface area measurement | 2.59e-03 | 20 | 112 | 2 | EFO_0004771 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.60e-03 | 150 | 112 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | platelet-to-lymphocyte ratio | 2.67e-03 | 363 | 112 | 6 | EFO_0008446 | |
| Disease | Congenital diaphragmatic hernia | 2.86e-03 | 21 | 112 | 2 | C0235833 | |
| Disease | glaucoma | 2.86e-03 | 154 | 112 | 4 | MONDO_0005041 | |
| Disease | asthma (is_implicated_in) | 3.07e-03 | 157 | 112 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.28e-03 | 160 | 112 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.40e-03 | 264 | 112 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | cortical thickness | MCPH1 CLOCK FMNL2 BBS9 LRRIQ1 GNA13 PKHD1 ALCAM KIF5B PLCH1 PCCB | 3.41e-03 | 1113 | 112 | 11 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCFFFPSLTLETEDM | 271 | Q8N6Q1 | |
| SSCTMDVTFFPFDRQ | 151 | Q05901 | |
| CFIFSDVDLVPMDDR | 211 | O60909 | |
| DPSADRICLMFSDVT | 356 | Q8N7J2 | |
| MATNIPCEVVAFSDR | 71 | Q8NDM7 | |
| ECFFDDMESIPAVTT | 831 | P13569 | |
| SLDICFLRPVSFAME | 651 | A8MVX0 | |
| CVADPFEVTVMQDFF | 816 | P01024 | |
| ESCDFVRAMVDPAQT | 611 | P50416 | |
| DEFCPVLDATFVMVA | 191 | Q9Y305 | |
| VRIFDEVMGCFSDSP | 1246 | Q13085 | |
| MTVEFEECVKDSPRF | 1 | Q96P50 | |
| MEAGSVVRAIFDFCP | 1 | Q6XZF7 | |
| MRCVSVLRFDSSAPF | 1241 | Q9HCU4 | |
| DSFPLMEISTCETEA | 16 | A1A5B4 | |
| DAELSPVATFRSCME | 176 | P80365 | |
| IMEPTECSELSEFVS | 141 | Q6IPU0 | |
| IDCEVFESRFPTTMA | 886 | Q93084 | |
| CATATAFARMTETPI | 271 | Q6VN20 | |
| TTAYMPVDFEDCSDR | 531 | Q17RG1 | |
| RFVCSPDEVMDTIDE | 171 | P33176 | |
| TDECPIAVFMVVFQS | 151 | P63252 | |
| QFVRFDSDSACPRME | 56 | P17693 | |
| LSCVDTFGTEMVSFV | 186 | Q8N0Y5 | |
| TPSSTVFFCCDMQER | 111 | Q96CN7 | |
| PATMVRVNATCRFEE | 821 | Q9BXT6 | |
| ERTSIFEMSDFSCVG | 451 | Q8NEM0 | |
| VEFCSTPAEKMAETV | 326 | Q9H2G9 | |
| LRVPFVVDICSMTFE | 786 | O95714 | |
| GTTVRVSFDFSCLEM | 46 | Q5T1J6 | |
| CSASPSSEMVTLEEF | 1661 | Q9P219 | |
| TVMVADCSRFDSPDL | 251 | Q969U6 | |
| CVSPSDRDFMETLNT | 346 | O75037 | |
| SRSSVEMDCFFPLVK | 1711 | O60229 | |
| VMIACVSPSSSDFDE | 321 | Q2M1P5 | |
| CPEEESIIMSSFVSI | 451 | P55160 | |
| SCGEARVTFSMDAFV | 311 | Q6B0I6 | |
| FMETTVFCTSEDGLV | 1116 | Q8IZD2 | |
| PFECSQSEVMFLSLD | 506 | Q9Y616 | |
| MADFLPSRSVLSVCF | 1 | Q14344 | |
| CELIDMETTTTFPRV | 231 | Q6UWI2 | |
| MSPEECRRFTTDAIA | 166 | P28065 | |
| MLFCLTSRCPEEFES | 311 | Q02509 | |
| PEDLCFSLQETVFAM | 226 | Q9NPF4 | |
| ELTCDQFTFEFMTPD | 466 | Q3SYG4 | |
| EFMRSKTDCATPDFV | 121 | Q96JM4 | |
| VCPEDESIIMSSFVN | 451 | Q9Y2A7 | |
| DTEILPSLFMRCTTD | 256 | Q9Y2X0 | |
| PGSFVESDMFVEHRC | 76 | P05166 | |
| PLVETIFERGMATCF | 296 | O00139 | |
| DEFLFTPVVVACMSI | 511 | P07333 | |
| SVTFSTECRMPDIAL | 4861 | Q4G0P3 | |
| CMDDVCPTEFEFVTT | 501 | Q9Y625 | |
| ERVQSVDFMRTDPVC | 276 | Q9P2G3 | |
| DRMTSQEAACFPDII | 186 | O60341 | |
| ELSEIFDPTRECMSS | 351 | Q16254 | |
| ETMRIASSEFADDPC | 101 | P26232 | |
| SSMCVPDQDTAIRVF | 211 | P01871 | |
| RRFPTMEAFLCEVTS | 31 | A2VCK2 | |
| DFVECLMRFLPTEAE | 676 | Q8IVF7 | |
| AFCTLPTREVFLEAM | 161 | Q5TA50 | |
| RPEVFSDNMFCVGDE | 411 | Q9NZP8 | |
| DFVECLMRFLPTENE | 731 | Q96PY5 | |
| MPSFEEICVFSRTLF | 141 | Q96JA4 | |
| AINPCSDTTMTAEEF | 121 | P43080 | |
| EFTASMESKICPFTI | 596 | Q96P70 | |
| MSRFCEAEFSVKTRP | 241 | Q16610 | |
| FVCMLVTEDNVFEAP | 111 | Q13740 | |
| DTDVILMCFSIDSPD | 76 | P08134 | |
| VDPEFADMITVQEFC | 191 | Q02241 | |
| MPTEESRSRYFLDEC | 566 | Q9P2E2 | |
| DISMRTVDCPFTVTF | 101 | P52564 | |
| VNSRPMFISAVEDCE | 1481 | P11717 | |
| FCAVPEGSENDMRFV | 161 | P53609 | |
| VDFDSDPMEECLRIF | 606 | Q8N1G1 | |
| DPMEECLRIFNESTS | 611 | Q8N1G1 | |
| SFESCFMRVSLLPDE | 186 | Q8IV01 | |
| IMPDRLDTSVSCFVV | 101 | Q9P2Y5 | |
| DTDVILMCFSIDSPD | 76 | P61586 | |
| DTDVILMCFSVDSPD | 76 | P62745 | |
| ESFGEVPSATVEMFC | 261 | Q96JX3 | |
| MFAFPEAREVAASCR | 161 | Q14DG7 | |
| ICDRTATPLDAFRMT | 91 | Q9NXC2 | |
| MTSTIGFRVFSCLDD | 286 | Q8N4C6 | |
| ETSRNMLEPTITCFD | 136 | P49798 | |
| FRIPFFMSQDCESLI | 241 | A0A0B4J2F2 | |
| FRIPFFMSQDCESLI | 241 | P57059 | |
| CTLFIREEASPVMDA | 1476 | P08F94 | |
| SLCDVLSMDFPFEVD | 241 | O95149 | |
| FMPSDRSTERCETVL | 91 | P12755 | |
| FVDMFSVLCESAPRE | 91 | O75838 | |
| EFLAFESVLCAPDSM | 76 | O75746 | |
| ESVLCAPDSMFIVAF | 81 | O75746 | |
| MCTVEEPNEEFTSRH | 266 | O15516 | |
| MEEVTTCSFNSPLFR | 1 | Q9UQ49 | |
| EMVDESPAMCSSFTR | 41 | Q96N38 | |
| MDCVIFEEVAVNFTP | 1 | Q15935 | |
| IMPRDDIFVYEVCST | 556 | Q13107 | |
| FREDMPSILADVFCI | 76 | Q8NI27 | |
| MTRFSEEACAVLTSP | 576 | P04275 | |
| CFISRHSIPSEMEFD | 106 | P62487 | |
| TEEFLMECGRFITPA | 71 | Q8IXW5 | |
| VDLITTGDFMSRFCS | 206 | Q00403 | |
| ACVSPSDRDFMETLN | 346 | Q7Z4S6 | |
| PMEHCTTRFFETCDL | 261 | P09486 | |
| EDLAMFRSIPNCTVF | 436 | Q9H0I9 | |
| DEAVDVTPVMTCVFV | 216 | Q8TCT7 | |
| FTCLFMSPVEDQLFR | 236 | Q8IZM8 | |
| TCDTDFLRPSDTVMQ | 196 | Q8TDW4 | |
| RSADEPMTTFVLCNE | 326 | O75764 | |
| MASISEPVTFREFCP | 1 | O15040 | |
| FSLSDVSMLCSDIPD | 1151 | Q4KWH8 | |
| DTMELFIETLTGTCF | 26 | Q86XD8 | |
| RPRYVFMEFCVEDST | 56 | E9PB15 | |
| EVAFSSAEMLVDCVP | 861 | P53814 | |
| LSFPEIMAVSSSREC | 1511 | Q13402 |